RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+21.75%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.87B
AUM Growth
+$3.87B
(+13%)
Cap. Flow
+$152M
Cap. Flow
% of AUM
3.92%
Top 10 Holdings %
Top 10 Hldgs %
35.18%
Holding
134
New
3
Increased
60
Reduced
11
Closed
5
Top Buys
| 1 |
Immunocore
IMCR
|
$38.6M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$36.8M |
| 3 |
Akero Therapeutics
AKRO
|
$23.5M |
| 4 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$20.7M |
| 5 |
Gossamer Bio
GOSS
|
$19M |
Top Sells
Sector Composition
| 1 | Healthcare | 96.8% |
| 2 | Consumer Staples | 0.91% |
| 3 | Industrials | 0.67% |
| 4 | Financials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPTX
126
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| – | – |
-271,787
| Closed | -$20.5M |
|
|
FUSN
127
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| – | – |
-809,854
| Closed | -$2.02M |
|
128
Prelude Therapeutics
PRLD
$69.1M
| – | – |
-368,959
| Closed | -$1.93M |
|